Javascript must be enabled to continue!
Dose-Dependent Cardioprotection of Pterocarpus indicus Extract in Rats With Myocardial Ischemia: Targeting Oxidative Stress, Inflammation, and Apoptosis
View through CrossRef
Background and Aim
This study investigated the dose-dependent cardioprotective effects of Pterocarpus indicus extract (P.indicus; LD: 27, MD: 54, HD: 108 mg/kg) against isoproterenol (ISO)-induced myocardial ischemia in rats, focusing on oxidative stress, apoptosis, inflammation, and fibrosis.
Experimental procedure
Rats were pretreated for 14 days and divided into control, ISO, propranolol, and P.indicus (LD, MD, HD) groups. Myocardial injury was assessed via ECG, histopathology, serum biomarkers (CK-MB, LDH, cTnT, IL-6, IL-1β, TNF-α), oxidative markers (SOD, MDA, GSH-Px), and apoptosis-related proteins (Bax, Bcl-2, Caspase-3). Nrf2/HO-1 expression was analyzed by western blot. Phytochemical profiling was performed via UPLC-MS/MS and HPLC. Pharmacokinetics, safety, and therapeutic-regimen efficacy were also evaluated.
Results
P.indicus at MD and HD significantly attenuated ISO-induced ECG abnormalities, histopathological damage, serum injury markers, inflammatory cytokines, and fibrosis (all
P
< 0.01). Treatment suppressed oxidative stress (restored SOD/GSH-Px, reduced MDA) via Nrf2/HO-1 activation and inhibited apoptosis via Bax/Bcl-2/Caspase-3 modulation. The efficacy of MD (EC
50
∼50 mg/kg) was confirmed by dose-response analysis. Pharmacological inhibition established that both Nrf2 activation and caspase-3 inhibition are necessary for P.indicus’s effects. PK studies showed systemic exposure to key compounds (quercetin-3-O-glucoside, ferulic acid, linoleic acid), and a 14-day safety assessment revealed no hepatorenal toxicity. Post-injury therapeutic administration also conferred significant protection.
Conclusion
P. indicus extract confers dose-dependent cardioprotection against ISO-induced myocardial injury through dual modulation of the Nrf2/HO-1 and Bax/Bcl-2/Caspase-3 pathways, with the medium dose (54 mg/kg) identified as optimally effective and well-tolerated.
Title: Dose-Dependent Cardioprotection of Pterocarpus indicus Extract in Rats With Myocardial Ischemia: Targeting Oxidative Stress, Inflammation, and Apoptosis
Description:
Background and Aim
This study investigated the dose-dependent cardioprotective effects of Pterocarpus indicus extract (P.
indicus; LD: 27, MD: 54, HD: 108 mg/kg) against isoproterenol (ISO)-induced myocardial ischemia in rats, focusing on oxidative stress, apoptosis, inflammation, and fibrosis.
Experimental procedure
Rats were pretreated for 14 days and divided into control, ISO, propranolol, and P.
indicus (LD, MD, HD) groups.
Myocardial injury was assessed via ECG, histopathology, serum biomarkers (CK-MB, LDH, cTnT, IL-6, IL-1β, TNF-α), oxidative markers (SOD, MDA, GSH-Px), and apoptosis-related proteins (Bax, Bcl-2, Caspase-3).
Nrf2/HO-1 expression was analyzed by western blot.
Phytochemical profiling was performed via UPLC-MS/MS and HPLC.
Pharmacokinetics, safety, and therapeutic-regimen efficacy were also evaluated.
Results
P.
indicus at MD and HD significantly attenuated ISO-induced ECG abnormalities, histopathological damage, serum injury markers, inflammatory cytokines, and fibrosis (all
P
< 0.
01).
Treatment suppressed oxidative stress (restored SOD/GSH-Px, reduced MDA) via Nrf2/HO-1 activation and inhibited apoptosis via Bax/Bcl-2/Caspase-3 modulation.
The efficacy of MD (EC
50
∼50 mg/kg) was confirmed by dose-response analysis.
Pharmacological inhibition established that both Nrf2 activation and caspase-3 inhibition are necessary for P.
indicus’s effects.
PK studies showed systemic exposure to key compounds (quercetin-3-O-glucoside, ferulic acid, linoleic acid), and a 14-day safety assessment revealed no hepatorenal toxicity.
Post-injury therapeutic administration also conferred significant protection.
Conclusion
P.
indicus extract confers dose-dependent cardioprotection against ISO-induced myocardial injury through dual modulation of the Nrf2/HO-1 and Bax/Bcl-2/Caspase-3 pathways, with the medium dose (54 mg/kg) identified as optimally effective and well-tolerated.
Related Results
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Objective
To observe time dependent effects of simulated ischemia-reperfusion on transient sodium currents (INa) in rat left ventricular myocytes, and effects of ...
Phytochemical Screening and Acute Exposure of Methanolic Bark Extract of Pterocarpus Tinctorius in Wistar Rats
Phytochemical Screening and Acute Exposure of Methanolic Bark Extract of Pterocarpus Tinctorius in Wistar Rats
The bark extract of Pterocarpus tinctorius (Fabaceae) is traditionally used to treat diseases such as diabetes, gonorrhoea, hypertension, stomachache and bacterial gastroenteritis....
Evaluation of anxiolytic potential of ethanol root extract and fractions of Pterocarpus mildbraedii in mice
Evaluation of anxiolytic potential of ethanol root extract and fractions of Pterocarpus mildbraedii in mice
To evaluate the anxiolytic potential of ethanol root extract and fractions of Pterocarpus mildbreadii in mice. Elevated-I-maze model apparatus is a straight wooden passage, divided...
An adenosinergic positive feedback loop extends pharmacological cardioprotection duration
An adenosinergic positive feedback loop extends pharmacological cardioprotection duration
AbstractBackground and PurposeAdenosine receptor activation induces delayed, sustained cardioprotection against ischaemia–reperfusion (IR) injury (24–72 h), but the mechanisms unde...
The combination of Pitavastain and ischemic postconditioning attenuates myocardial ischemic/reperfusion injury in impaired glucose tolerance rat in vivo
The combination of Pitavastain and ischemic postconditioning attenuates myocardial ischemic/reperfusion injury in impaired glucose tolerance rat in vivo
Background and Objectives
Myocardial ischemia-reperfusion injury (MIRI) can be alleviated by ischemia post-conditioning (IPC) and/or statin post-conditioning (SPC...
THE STUDY OF APOPTOSIS MECHANISM IN THE PROCESS OF RECOMBINANT INTERLEUKIN-12 TREAT THE MICE WITH VIRAL MYOCARDITIS
THE STUDY OF APOPTOSIS MECHANISM IN THE PROCESS OF RECOMBINANT INTERLEUKIN-12 TREAT THE MICE WITH VIRAL MYOCARDITIS
Objectives
Through studying the NK cell activity, the pathological changes of myocardial cells and the changes of apoptosis in the process of recombinant interleu...
DJ-1 overexpression restores ischaemic post-conditioning-mediated cardioprotection in diabetic rats: role of autophagy
DJ-1 overexpression restores ischaemic post-conditioning-mediated cardioprotection in diabetic rats: role of autophagy
IPO (ischaemic post-conditioning) is a promising method of alleviating myocardial IR (ischaemia-reperfusion) injury; however, IPO-mediated cardioprotection is lost in diabetic hear...
Repeated remote ischemic preconditioning enhances post‐ischemic myocardial STAT5A and STAT3 but not STAT5B to confer cardioprotection in diabetic rats
Repeated remote ischemic preconditioning enhances post‐ischemic myocardial STAT5A and STAT3 but not STAT5B to confer cardioprotection in diabetic rats
Background
Remote ischemic preconditioning (RIPC) protects the hearts from ischemia/reperfusion (I/R) injury experimentally. In patients undergoing cardiac surg...

